Kamilla Enggaard Have

Kamilla Enggaard Have serves as the Board Member and Managing Director of Jazz Pharmaceuticals Aps, leading strategic initiatives and governance for the Nordic cluster across five countries with a focus on Environmental, Social and Governance principles. Kamilla has transformed Jazz Nordics from a negative operating margin in 2021 to a positive 20% in 2023 through significant revenue growth and a high level of employee satisfaction. Kamilla also lectures on Pharmaceutical Marketing Management at Copenhagen Business School, having designed a comprehensive Master's curriculum. Prior experience includes leadership roles at Novo Nordisk, Takeda, and sanofi-aventis UK, where Kamilla managed global marketing strategies, product launches, and cross-functional teams in specialist care. Educational qualifications include a Master of Science in Pharmacy and a Bachelor of Commerce with a focus on Business Administration and Management.